98 related articles for article (PubMed ID: 2402742)
21. Practical application of the protein C activator Protac from Agkistrodon contortrix venom.
Stocker K; Fischer H; Meier J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):260-4. PubMed ID: 2465212
[TBL] [Abstract][Full Text] [Related]
22. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors.
Pabinger I; Schneider B
Thromb Haemost; 1994 May; 71(5):548-52. PubMed ID: 8091378
[TBL] [Abstract][Full Text] [Related]
23. Multicenter comparison of five functional and two immunological assays for protein C.
Mannucci PM; Boyer C; Tripodi A; Viganò-D'Angelo S; Wolf M; Valsecchi C; D'Angelo A; Meyer D; Larrieu MJ
Thromb Haemost; 1987 Feb; 57(1):44-8. PubMed ID: 3590079
[TBL] [Abstract][Full Text] [Related]
24. Functional assays for protein C activity and protein C inhibitor activity in plasma.
Geiger M; White TM; Griffin JH
Thromb Haemost; 1989 Feb; 61(1):86-92. PubMed ID: 2546280
[TBL] [Abstract][Full Text] [Related]
25. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
Favaloro EJ; Mirochnik O; McDonald D
Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
[TBL] [Abstract][Full Text] [Related]
26. A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S.
van Wijnen M; van 't Veer C; Meijers JC; Bertina RM; Bouma BN
Thromb Haemost; 1998 Dec; 80(6):930-5. PubMed ID: 9869163
[TBL] [Abstract][Full Text] [Related]
27. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.
Gladson CL; Scharrer I; Hach V; Beck KH; Griffin JH
Thromb Haemost; 1988 Feb; 59(1):18-22. PubMed ID: 2966450
[TBL] [Abstract][Full Text] [Related]
28. [Constitutional protein C deficiency in 57 patients from 22 non-related families].
Horellou MH; Conard J; Van Dreden P; Samama M
Ann Med Interne (Paris); 1986; 137(6):465-70. PubMed ID: 3813281
[TBL] [Abstract][Full Text] [Related]
29. The incidence of protein C deficiency in thrombosis-related portal hypertension.
Majluf-Cruz A; Hurtado Monroy R; Sansores García L; Labardini-Méndez J
Am J Gastroenterol; 1996 May; 91(5):976-80. PubMed ID: 8633591
[TBL] [Abstract][Full Text] [Related]
30. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
[TBL] [Abstract][Full Text] [Related]
31. Protein C and protein S assessment in hospital laboratories: which strategy and what role for DNA sequencing?
Labrouche S; Reboul MP; Guérin V; Vergnes C; Freyburger G
Blood Coagul Fibrinolysis; 2003 Sep; 14(6):531-8. PubMed ID: 12960605
[TBL] [Abstract][Full Text] [Related]
32. An international collaborative study on the performance of protein C antigen assays. Report of the ICTH subcommittee on protein C. International Committee on Thrombosis and Haemostasis.
Bertina RM
Thromb Haemost; 1987 Feb; 57(1):112-7. PubMed ID: 3590075
[TBL] [Abstract][Full Text] [Related]
33. A simple functional protein S assay using PROTAC.
Han P; Pradham M
Clin Lab Haematol; 1990; 12(2):201-8. PubMed ID: 2145113
[TBL] [Abstract][Full Text] [Related]
34. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study.
Pabinger I; Kyrle PA; Heistinger M; Eichinger S; Wittmann E; Lechner K
Thromb Haemost; 1994 Apr; 71(4):441-5. PubMed ID: 8052960
[TBL] [Abstract][Full Text] [Related]
35. [Protein C deficiency and vascular thromboses. Apropos of 2 cases and a review of the literature].
Debrueres-Gris S; Lekieffre J; Werquin S; Kacet S; Jude B
Arch Mal Coeur Vaiss; 1989; 82(8):1459-65. PubMed ID: 2508600
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of coagulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S.
D'Angelo SV; Gilardoni F; D'Angelo A
Thromb Haemost; 1989 Nov; 62(3):861-7. PubMed ID: 2531939
[TBL] [Abstract][Full Text] [Related]
37. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
38. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
[TBL] [Abstract][Full Text] [Related]
39. Protein C.
Esmon CT
Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
[TBL] [Abstract][Full Text] [Related]
40. Marked discrepancy between coagulometric protein C activity assays with the pro-thrombotic protein C Asn2Ile substitution.
Cooper PC; Siddiq S; Morse C; Nightingale J; Mumford AD
Int J Lab Hematol; 2011 Oct; 33(5):451-6. PubMed ID: 21418542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
